✦ LIBER ✦

Alendronate and vitamin D2 for prevention of hip fracture in Parkinson's disease: A randomized controlled trial

✍ Scribed by Yoshihiro Sato; Jun Iwamoto; Tomohiro Kanoko; Kei Satoh

Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 74 KB
Volume: 21
Category: Article
ISSN: 0885-3185
DOI: 10.1002/mds.20825

No coin nor oath required. For personal study only.

✦ Synopsis

The above article, published online on 14 March 2006 in Wiley Online Library (wileyonlinelibrary.com), and in Volume 21, Issue 7, Pages 924–929, has been retracted by agreement between the authors, the Editor‐in‐Chief, Jose A. Obeso, and Wiley Periodicals, Inc. The retraction has been agreed due to an acknowledgement from the authors that the co‐authors did not participate in study design, data collection, data analysis, interpretation of data and drafting the manuscript. Thus all co‐authors are honorary.

Reference

Sato, Y.,
Iwamoto, J.,
Kanoko, T., and
Satoh, K. (2006) . Mov Disord. doi: 10.1002/mds.20825

📜 SIMILAR VOLUMES

A pilot randomized controlled trial of s

A pilot randomized controlled trial of sleep therapy in Parkinson's disease: effect on patients and caregivers

✍ Iracema Leroi; Peter Baker; Pam Kehoe; Emily Daniel; E Jane Byrne 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB 👁 2 views

## Abstract ## Objective By means of a controlled trial, to investigate the efficacy, tolerability and feasibility of a multi‐component sleep therapy intervention versus basic sleep hygiene education in PD patients with sleep disturbances and their live‐in carers. ## Methods Patient‐carer dyads

Self-management rehabilitation and healt

Self-management rehabilitation and health-related quality of life in Parkinson's disease: A randomized controlled trial

✍ Linda Tickle-Degnen; Terry Ellis; Marie H. Saint-Hilaire; Cathi A. Thomas; Rober 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 312 KB 👁 1 views

## Abstract The purpose of this randomized controlled trial was to determine whether increasing hours of self‐management rehabilitation had increasing benefits for health‐related quality of life (HRQOL) in Parkinson's disease beyond best medical treatment, whether effects persisted at 2 and 6 month

Effect of alendronate and vitamin D3 on

Effect of alendronate and vitamin D3 on fractional calcium absorption in a double-blind, randomized, placebo-controlled trial in postmenopausal osteoporotic women

✍ Sue A Shapses; David L Kendler; Richard Robson; Karen E Hansen; Robert M Sherrel 📂 Article 📅 2011 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 127 KB 👁 1 views

## Abstract Menopause and increasing age are associated with a decrease in calcium absorption that can contribute to the pathogenesis of osteoporosis. We hypothesized that alendronate plus vitamin D~3~ (ALN + D) would increase fractional calcium absorption (FCA). In this randomized, double‐blind, p

Increasing access to specialty care: A p

Increasing access to specialty care: A pilot, randomized controlled trial of telemedicine for Parkinson's disease

✍ E. Ray Dorsey; Lisa M. Deuel; Tiffini S. Voss; Kara Finnigan; Benjamin P. George 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 231 KB 👁 2 views

## Abstract We conducted a randomized, controlled pilot trial to evaluate the feasibility of providing subspecialty care via telemedicine for patients with Parkinson's disease residing in a remote community located ∼130 miles from an academic movement disorders clinic. Study participants were rando

A randomized controlled trial of movemen

A randomized controlled trial of movement strategies compared with exercise for people with Parkinson's disease

✍ Meg E. Morris; Robert Iansek; Beth Kirkwood 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 1 views

## Abstract This randomized controlled clinical trial was conducted to compare the effects of movement rehabilitation strategies and exercise therapy in hospitalized patients with idiopathic Parkinson's disease. Participants were randomly assigned to a group that received movement strategy training

Double-blind, randomized, controlled tri

Double-blind, randomized, controlled trial of rasagiline as monotherapy in early Parkinson's disease patients

✍ Matthew B. Stern; Kenneth L. Marek; Joseph Friedman; Robert A. Hauser; Peter A. 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB 👁 2 views

## Abstract Rasagiline (__N__‐propargyl‐1(__R__)‐aminoindan) mesylate is a potent, selective, and irreversible monoamine oxidase‐B inhibitor. This study was designed to evaluate the safety, tolerability, and preliminary efficacy of rasagiline monotherapy in early Parkinson's disease (PD) patients n